CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS by V. I. Podzolkov, A. I. Tarzimanova, I. Z. Loriya

Subjects: Get full text

Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction by Junichi Ohno, Kyung‐Duk Min, Isamu Sunayama, Yuki Matsumoto, Aika Daimon, Eri Manabe, Makiko Oboshi, Kohei Azuma, Masataka Sugahara, Akiyo Eguchi, Yoshiro Naito, Masanori Asakura, Masaharu Ishihara

Subjects: “…atrial natriuretic peptide (ANP)…”
Get full text

ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? by T. A. Kazakovtseva, N. A. Shostak

“…To evaluate sensitivity of laboratory markers of HF, brain (BNP) and atrial (ANP) natriuretic peptides, in patients with mitral heart diseases of rheumatic aetiology.Material and methods. 100 patients with rheumatic mitral disease and chronic HF (CHF) of I-IV class (NYHA) were examined. …”
Get full text

Combining clinical markers can predict mortality in NYHA IV heart failure by Yi-jiao Men, Yan-ling Dong, Yu Gong, Ya-qing An, Hong-bo Cheng

“…Abstract Early assessment of heart failure during treatment can improve patient prognosis. Brain natriuretic peptide (BNP), uric acid (UA), pre-albumin (PA), red blood cell distribution width (RDW), and Cystatin C (Cys C) are related to the development of heart failure. …”
Get full text

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS by Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina

“…The change in 24-hour diuresis and natriuresis, fractional urinary sodium excretion, and BP level have been studied, as-well as soluble biomarkers: cyclic guanosine monophosphate (cGMP), plasma brain natriuretic peptide (BNP), mid-regional precursor of the atrial natriuretic-peptide (MR-proANP) and the N-terminal precursor of the brain natriuretic peptide (NT-proBNP).Results. …”
Get full text

Current Predictors of Atrial Fibrillation Progression by V. I. Podzolkov, A. I. Tarzimanova

“…Reduction in LV ejection fraction below 40% (OR 0.84; 95%CI 0.7-0.89) and increased plasma N-terminal pro-B-type natriuretic peptide (Nt-proBNP; OR 2.3; 95%CI 1.93-2.67) were independent predictors of AF progression from persistent to permanent form in the patients with systolic heart failure.Conclusion. …”
Get full text

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report by E. A. Pravkina, E. N. Kochnova, K. G. Pereverzeva, S. S. Yakushin

Get full text

Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation by Pascal B. Meyre, Stefanie Aeschbacher, Steffen Blum, Tobias Reichlin, Moa Haller, Nicolas Rodondi, Andreas S. Müller, Alain Bernheim, Jürg Hans Beer, Giorgio Moschovitis, André Ziegler, Bianca Wahrenberger, Elia Rigamonti, Giulio Conte, Philipp Krisai, Leo H. Bonati, Stefan Osswald, Michael Kühne, David Conen

“…We identify 5 biomarkers including D-dimer, growth differentiation factor 15 (GDF-15), interleukin-6 (IL-6), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and high-sensitivity troponin T (hsTropT) that independently predict cardiovascular death, stroke, myocardial infarction, and systemic embolism, significantly enhancing predictive accuracy. …”
Get full text

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction by Nicolas Johner, Mehdi Namdar, Dipen C Shah

“…However, catheter ablation has been reported to result in lower natriuretic peptides, lower filling pressures, greater peak cardiac output and improved functional capacity in HFpEF. …”
Get full text

Troponin, NT-proBNP and postoperative atrial fibrillation in a prospective cohort undergoing coronary artery bypass surgery by Amelie H. Ohlrogge, Ferdinand Seum, Korbinian Ruhland, Francisco M. Ojeda, Christin S. Börschel, Simon Pecha, Stefan Blankenberg, Tanja Zeller, Renate B. Schnabel

“…Abstract Troponin and N-terminal pro B-type natriuretic peptide (NT-proBNP) are biomarkers of cardiac damage and myocyte stretch. …”
Get full text

Cardiorenal relationships in the focus of risks of atrial fibrillation in patients after acute ST-elevated myocardial infarction (observational program FAKEL) by I. A. Zolotovskaya, I. L. Davydkin, D. V. Duplyakov, V. A. Kokorin

“…There were 4 visits: V1 - inclusion visit, V2 - in 12 months, V3 - in 18 months, V4- in 24 months with determination of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP), cystatin C, erythropoietin, galectin-3, von Willebrand factor (fW), left ventricular ejection fraction. …”
Get full text

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration by I. V. Gribkova

“…The effectiveness and tolerability of vericiguat, the dependence of its action on the initial state of patients (the presence of coronary heart disease, atrial fibrillation, renal failure, the level of N-terminal pro b-type natriuretic peptide (NT-proBNP) and the duration of the period after hospitalization) are considered. …”
Get full text

Inflammatory pathways in transfusion-associated circulatory overload by RoseAnn E. Vik, Esther B. Bulle, Wilmore C. Webley, Paul Visintainer, Samantha Ramirez, Peter St. Marie, Theresa Stec, Lynne O’Hearn, Chester Andrzejewski, Jr., Alexander P. J. Vlaar

“…Samples were analyzed for levels of tumor necrosis factor α, interleukin-1α (IL-1α), IL-6, IL-8, IL-10, C-reactive protein, intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1, atrial natriuretic peptide, cardiac troponin, and N-terminal pro–B-type natriuretic peptide. …”
Get full text

Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy by F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, D. A. Yatsenko, А. V. Emelianov, A. S. Lishuta, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov

“…In accordance with the assigned tasks, all patients underwent determination of biological markers of neurohumoral systems in blood serum using immunofluorescence assay analysis: N-terminal fragment of brain natriuretic peptide (NT-proBNP), von Willebrand factor (vWF), endothelin-1, E-selectin with subsequent evaluation and correlation of results with clinical and instrumental characteristics of patients. …”
Get full text

The diagnostic yield of non-invasive testing features in cardiac amyloidosis by Domagoj Kustić, Josipa Vukšić, Dražen Huić

“…Troponin T, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and various ECG and echocardiographic features were compared between ATTR scintigraphy-positive and negative participants using the t-test, Mann–Whitney U-test, and χ2-test as appropriate. …”
Get full text

Dose-dependent renoprotective effects of sacubitril/valsartan in heart failure: a retrospective study by Takahiro Kato, Yusuke Nakano, Noriko Yasukawa, Masafumi Oonishi, Yukihiro Hamada

“…This retrospective observational study included patients with heart failure (Stage B or higher, B-type natriuretic peptide (BNP) >100 pg/mL or N-terminal proBNP >300 pg/mL) who initiated sacubitril/valsartan (SV) treatment. …”
Get full text

Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction by A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh

“…Data of echocardiography and 24-hour ECG monitoring, indicis of rating scale of clinical state in patients with heart failure (RSCS, Mareev V.Y, 2000), results of determination of plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) and of six-minute walk test were also analyzed.Results. …”
Get full text